Sankar, S., Kalidass, B., Indrakumar, J., & Kodiveri Muthukaliannan, G. (2025). NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression. Inflammopharmacology: Experimental and Therapeutic Studies, 1-30. https://doi.org/10.1007/s10787-025-01760-8
Chicago Style (17th ed.) CitationSankar, Srivarshini, Bharathi Kalidass, Janani Indrakumar, and Gothandam Kodiveri Muthukaliannan. "NSAID-encapsulated Nanoparticles as a Targeted Therapeutic Platform for Modulating Chronic Inflammation and Inhibiting Cancer Progression." Inflammopharmacology: Experimental and Therapeutic Studies 2025: 1-30. https://doi.org/10.1007/s10787-025-01760-8.
MLA (9th ed.) CitationSankar, Srivarshini, et al. "NSAID-encapsulated Nanoparticles as a Targeted Therapeutic Platform for Modulating Chronic Inflammation and Inhibiting Cancer Progression." Inflammopharmacology: Experimental and Therapeutic Studies, 2025, pp. 1-30, https://doi.org/10.1007/s10787-025-01760-8.